Injectable Nanomedicines Market Size By Drug Type (Mesoporous Silica Nanoparticles, Polymeric Nanoparticles, Micelles, Liposomes, Metallic Nanoparticles and Others), By Application (Inflammatory Diseases, Cancers, Cardiovascular Diseases, Central Nervous System Diseases, Infection Control and Others), Regions, Segmentation, and forecast till 2030.
Pune India, Jan. 06, 2023 (GLOBE NEWSWIRE) — The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the injectable nanomedicines market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the injectable nanomedicines market are present across various countries in the above-mentioned regions.
Get Sample Copy of This Report @ https://greyviews.com/reports/injectable-nanomedicines-market/301/request-sample
The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as the drug type, application, and regions. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.
The significant players operating in the global Injectable Nanomedicines Market are INJEX, West Pharmaceuticals, Pfizer Inc., Elcam Medical, Infineon Technologies AG, Baxter International Inc, SCHOTT AG, Becton Dickinson and Company, Eli Lily and Company, Sanofi SA, Teva Pharmaceuticals, Novartis AG, Lupin, Johnson & Johnson among others. To achieve a substantial market share in the worldwide Injectable Nanomedicines Market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
A nanomedicine administered via injection delivers the drug to the target site and allows it to accumulate there. Also, injectable nanomedicines improve their absorption through epithelial diffusion, thus reaching optimum concentrations in a very short period of time. Increasing attention to selective drug delivery and targeted therapies is another factor fueling demand for injectable nanomedicines. A more targeted approach to disease management is expected to lead to more demand for injectable nanomedicines. A number of injectable nanomedicines are under clinical trials and are anticipated to launch in recent years, which will increase the level of competition in the injectable nanomedicine market as major players invest in R&D for the development of innovative nanomedicines. With the rise of injectable nanomedicines, better outcomes and therapeutics are projected in areas as diverse as cancer, CNS diseases, infection control and cardiovascular disease. Market growth is driven by the ageing population as well as the increasing prevalence of infectious and chronic diseases in the country. Furthermore, new opportunities will be created in the injectable nanomedicine market over the forecasted period as technology advances, healthcare techniques are modernized, and research and development activities are increasing within the healthcare sector. Rising awareness about the benefits of injectable nanomedicines and research and development by major key players will add up more value to the market’s growth.
Enquiry Before Buying This Report @ https://greyviews.com/inquiry/301
Scope of Injectable Nanomedicines Market Report:
| Report Metric | Information |
| Study Period | 2022-2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Market Share Unit | USD Million |
| Segments Covered | Drug Type, Application, and Regions. |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle-East and Africa |
| Major Players | INJEX, West Pharmaceuticals, Pfizer Inc., Elcam Medical, Infineon Technologies AG, Baxter International Inc, SCHOTT AG, Becton Dickinson and Company, Eli Lily and Company, Sanofi SA, Teva Pharmaceuticals, Novartis AG, Lupin, Johnson & Johnson among others. |
Segmentation Analysis
Polymeric nanoparticles are expected to be the fastest-growing segment in 2022.
The drug type segment includes mesoporous silica nanoparticles, polymeric nanoparticles, micelles, liposomes, metallic nanoparticles and others. The polymeric nanoparticles segment is expected to witness the highest growth rate during the forecast period. In addition to improving drug bioavailability or specific drug delivery to the site of action, polymer nanoparticles are possible solutions that will meet the requirements of any drug-delivery system and propels the growth of the injectable nanomedicine market.
Cancers are expected to be the fastest-growing segment in 2022.
The application segment includes inflammatory diseases, cancers, cardiovascular diseases, central nervous system diseases, infection control and others. The cancer segment is expected to witness the highest growth rate during the forecast period. A genetically modifiable form of nanomedicine that is injectable can boost the immune response against cancerous tumours by serving as an adjuvant for vaccine therapy, or as a drug carrier for anti-cancer therapies that can more effectively target tumours while leaving normal tissues unharmed.
Regional Analysis
The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the injectable nanomedicines market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.
The North American region witnessed a major share. Four nanomedicine development centres will be established with US$ 42 million over five years under NIH’s Pathway to Discovery program. With this type of government funding, a large number of injectable nanomedicines are becoming available in treatment and diagnostic centres, which is contributing to the regional market’s growth.
Country Analysis
- Germany
Germany’s injectable nanomedicines market size was valued at USD 69.44 million in 2022 and is expected to reach USD 125.7 million by 2030, at a CAGR of 7.7% from 2023 to 2030.
Increasing the use of nanomedicines in drug discovery will drive the revenue growth of the country’s injectable nanomedicines market. In addition, several opportunities for growth in the nanomedicine market are expected to arise as nano-drug out-licensing increases and healthcare facilities expand across the nation.
- China
China’s injectable nanomedicines market size was valued at USD 47.32 million in 2022 and is expected to reach USD 86.29 million by 2030, at a CAGR of 7.8% from 2023 to 2030.
In China, nano-particle-based drug delivery is primarily driven by increasing cancer prevalence, the need to deliver better-quality healthcare services, and the increasing focus on boosting biologics, which is propelling the growth of the injectable nanomedicines market.
- India
India’s injectable nanomedicines market size was valued at USD 36.4 million in 2022 and is expected to reach USD 66.8 million by 2030, at a CAGR of 7.9% from 2023 to 2030.
As various infectious diseases become more prevalent in the country, investment in healthcare will further boost the market growth. Moreover, increasing ageing populations and a rising prevalence of chronic and infectious diseases drive the market’s growth in the country
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.
Furthermore, the growth of injectable nanomedicines market is mainly driven owing to the increasing demand from the healthcare sector and rising cases of cancer globally, propelling the growth of the market across the countries.
Buy Now Full Report @ https://greyviews.com/checkout/301/single_user_license
Contact Us
Rocky Shah
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: [email protected]
Web: https://greyviews.com/
Follow Us: LinkedIn | Twitter
Browse Related Reports:
Hemodynamic Monitoring System Market Size By System (Invasive Monitoring Systems, Minimally Invasive Monitoring Systems, and Non-invasive Monitoring Systems), By End-User (Catheterization Laboratories, Hospitals, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/hemodynamic-monitoring-system-market/372
Dermatology Lasers Market Size By Type (Gem Laser Machine, Gas Laser Machine, and Semiconductor Laser Machine), By Application (Beauty and Skin Diseases), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/dermatology-lasers-market/370
Pharmaceutical Glass Packaging Market Size By Product (Bottles, Vials, Cartridges & Syringes, and Ampoules), By Drug Type (Branded, Biologic and Generic), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/pharmaceutical-glass-packaging-market/367
Pharmaceuticals Preservative Market Size By Source (Natural Pharmaceuticals Preservative Agents and Synthetic Pharmaceuticals Preservative Agents), By Function (Antioxidants Pharmaceuticals Preservative Agents, Antimicrobial Pharmaceuticals Preservative Agents, and Chelating Pharmaceuticals Preservative Agents), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/pharmaceuticals-preservative-market/361
Ophthalmic Drugs Market Size By Drug Class (Anti-Inflammatory, Anti-Glaucoma, Anti-VEGF Agents, Antiallergy, and Others), By Disease (Glaucoma, Eye Allergy, Eye Infection, Uveitis, Dry Eye, Retinal Disorders, and Others), By Dosage Form (Eye Solutions & Suspensions, Eye Drops, Gels, Capsules and Tablets, and Ointments), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/ophthalmic-drugs-market/357
Neurosurgery Surgical Power Tools Market Size By Tools Type (Drill, Reamer, Saw, and Others), By Power Type (Pneumatic, Electric, and Battery Powered), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/neurosurgery-surgical-power-tools-market/356
Neonatal Phototherapy Devices Market Size By Light Source (Light-emitting diodes (LEDs), Quartz halogen lamps, Gas discharge tubes, and Fluorescent lamps (FL)), By Configuration (Mobile device and Fixed device), By End-User (Hospitals and Neonatal clinics), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/neonatal-phototherapy-devices-market/355
Minimally Invasive Cataract Surgery Devices Market Size By Type (Stand-Alone Glaucoma, Phacoemulsification, Glaucoma in Conjunction with Cataract, Femtosecond Laser Surgery and Extracapsular Cataract Extraction Surgery), By End-User (Ophthalmology Clinic, Hospitals, Outpatient Surgery Centre and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/minimally-invasive-cataract-surgery-devices-market/354
Healthcare Cold Chain Logistics Market Size By Type (Vaccines, Biopharmaceuticals, Clinical Trial Materials, and Others), By Services (Transportation, Storage, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/healthcare-cold-chain-logistics-market/353
Disposable Syringes Market Size By Product (Conventional Syringes and Safety Syringes), By Application (Immunization Injections and Therapeutic Injections), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/disposable-syringes-market/351
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaChron.com takes no editorial responsibility for the same.